Deletion of Amino Acids Glu146→Arg160 in Human Apolipoprotein A-I (ApoA-ISeattle) Alters Lecithin:Cholesterol Acyltransferase Activity and Recruitment of Cell Phospholipid
- 19 March 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (14) , 4863-4868
- https://doi.org/10.1021/bi972888i
Abstract
Human apolipoprotein A-I (apoA-I) has an important role in the efflux of cholesterol from peripheral cells, the first step in reverse cholesterol transport. Deletion of amino acids Glu146→Arg160 in apoA-I (apoA-ISeattle) removes a large section of a lipid binding helix and is associated in vivo with an atherogenic lipoprotein profile characterized by a deficiency in high-density lipoproteins (HDL). In the present study, we asked whether apoA-ISeattle had normal ability to recruit lipids from cells and to form nascent high-density lipoprotein (HDL) particles and whether the altered secondary structure affected lecithin:cholesterol acyltransferase (LCAT) activity. Wild-type apoA-I and apoA-ISeattle expressed in transfected Chinese hamster ovary cells formed nascent HDL particles with similar density distribution and protein-to-lipid ratio. Phospholipid subclass distribution of apoA-ISeattle nascent HDL demonstrated a significant increase in sphingomyelin and phosphatidylethanolamine compared to wild type. ApoA-ISeattle nascent HDL had a unique size distribution compared to wild-type nascent HDL; large (9−20 nm) particles predominated while there were virtually no small (7.5 nm) particles. LCAT reactivity was impaired by apoA-ISeattle nascent HDL where cholesterol esterification was only half that of wild-type complexes. The apoA-ISeattle conformation on nascent HDL was studied with a panel of monoclonal antibodies (Mabs) specific for apoA-I. Mabs that recognize the putative LCAT activation site, residues 95−122, had normal reactivity. As expected, the Mabs that recognized residues 141−164 were unreactive because of the 146−160 deletion; in addition, there was low reactivity with a Mab that recognizes residues 220−242. The data suggest that apoA-I residues 146−160 and/or 220−242 partake in normal LCAT activation and that cooperative interactions between helices may be important for maximal cholesterol esterification.Keywords
This publication has 13 references indexed in Scilit:
- Sphingomyelin Inhibits the Lecithin-Cholesterol Acyltransferase Reaction with Reconstituted High Density Lipoproteins by Decreasing Enzyme BindingJournal of Biological Chemistry, 1996
- Selection of monoclonal antibodies for linear epitopes of an apolipoprotein yields antibodies with comparable affinity for lipid-free and lipid-associated apolipoproteinJournal of Lipid Research, 1996
- ApoA-IHelsinki(Lys107→0) Associated With Reduced HDL Cholesterol and LpA-I:A-II DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCATJournal of Lipid Research, 1995
- Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction.Journal of Biological Chemistry, 1993
- Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles.Journal of Lipid Research, 1993
- The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.Journal of Lipid Research, 1992
- A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.Journal of Clinical Investigation, 1991
- Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.Journal of Clinical Investigation, 1980